Although the LAP’s ability to discriminate excess visceral fat is still little explored [11], studies indicate greater specificity of the LAP in the prediction of type 2 diabetes mellitus [32], metabolic syndrome [16], resistance to insulin [12], and risk of cardiovascular diseases [26] when compared to BMI. This evidence concerns the gene INS and metabolic syndrome.